中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
New Rufomycins from Streptomyces atratus MJM3502 Expand Anti- Mycobacterium tuberculosis Structure-Activity Relationships

文献类型:期刊论文

作者Zhou, Bin2,3,4,5; Shetye, Gauri3; Wolf, Nina M.3; Chen, Shao-Nong3,4,5; Qader, Mallique3; Ray, G. Joseph3,4,5; Lankin, David C.3,4,5; Cho, Sanghyun3; Cheng, Jinhua1; Suh, Joo-Won1
刊名ORGANIC LETTERS
出版日期2022-10-04
页码6
ISSN号1523-7060
DOI10.1021/acs.orglett.2c02493
通讯作者McAlpine, James B.(mcalpine@uic.edu) ; Pauli, Guido F.(gfp@uic.edu)
英文摘要Four new rufomycins, compounds 1-4, named rufomycins 56, 57, 58, and 61, respectively, exhibiting new skeletal features, were obtained from Streptomyces atratus strain MJM3502 and were fully characterized. Compounds 1 and 2 possess a 4imidazolidinone ring not previously encountered in this family of cyclopeptides, thereby resulting in a [5,17] bicyclic framework. The in vitro anti -Mycobacterium tuberculosis potency of compounds 3 and 4 is remarkable, with minimum inhibitory concentration values of 8.5 and 130 nM, respectively.
WOS关键词ABSOLUTE-CONFIGURATION
资助项目Centers of Excellence for Translational Research (CETR) Grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH)[U19AI142735] ; Cooperative Research Program for Agriculture Science and Technology Development[PJ01564001]
WOS研究方向Chemistry
语种英语
WOS记录号WOS:000868931300001
出版者AMER CHEMICAL SOC
源URL[http://119.78.100.183/handle/2S10ELR8/303256]  
专题新药研究国家重点实验室
通讯作者McAlpine, James B.; Pauli, Guido F.
作者单位1.Myongji Univ, Myongji Bioefficacy Res Ctr, Yongin 17058, Gyeonggi Do, South Korea
2.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China
3.Univ Illinois, Inst TB Res, Coll Pharm, Chicago, IL 60612 USA
4.Univ Illinois, Dept Pharmaceut Sci Coll Pharm, Chicago, IL 60612 USA
5.Univ Illinois, Pharmacognosy Inst, Coll Pharm, Chicago, IL 60612 USA
推荐引用方式
GB/T 7714
Zhou, Bin,Shetye, Gauri,Wolf, Nina M.,et al. New Rufomycins from Streptomyces atratus MJM3502 Expand Anti- Mycobacterium tuberculosis Structure-Activity Relationships[J]. ORGANIC LETTERS,2022:6.
APA Zhou, Bin.,Shetye, Gauri.,Wolf, Nina M..,Chen, Shao-Nong.,Qader, Mallique.,...&Pauli, Guido F..(2022).New Rufomycins from Streptomyces atratus MJM3502 Expand Anti- Mycobacterium tuberculosis Structure-Activity Relationships.ORGANIC LETTERS,6.
MLA Zhou, Bin,et al."New Rufomycins from Streptomyces atratus MJM3502 Expand Anti- Mycobacterium tuberculosis Structure-Activity Relationships".ORGANIC LETTERS (2022):6.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。